Edition:
United States

GeneNews Ltd (GEN.TO)

GEN.TO on Toronto Stock Exchange

0.31CAD
21 Feb 2017
Change (% chg)

$-0.01 (-3.12%)
Prev Close
$0.32
Open
$0.31
Day's High
$0.31
Day's Low
$0.30
Volume
797,735
Avg. Vol
503,172
52-wk High
$0.57
52-wk Low
$0.02

GEN.TO

Chart for GEN.TO

About

GeneNews Limited is focused on developing and commercializing molecular diagnostic tests for early detection of diseases and for personalized health management, with a primary focus on cancer-related indications. The Company offers Sentinel Principle, which is a platform technology to detect virtually any disease or medical... (more)
No analyst recommendations are available for GEN.TO.

Overall

Beta: --
Market Cap(Mil.): $25.38
Shares Outstanding(Mil.): 81.66
Dividend: --
Yield (%): --

Financials

  GEN.TO Industry Sector
P/E (TTM): -- 46.79 29.35
EPS (TTM): -0.18 -- --
ROI: -- -3.72 12.97
ROE: -- 4.91 14.11

BRIEF-Genenews Q3 loss per share $0.04

* Genenews announces Q3-2016 financial results and provides corporate update

Nov 11 2016

BRIEF-GeneNews provides update on GEM and Alumina Financings

* GeneNews provides update on GEM and Alumina Financings Source text for Eikon: Further company coverage:

Oct 03 2016

BRIEF-GeneNews and NueHealth announce partnership in early cancer diagnostics

* GeneNews and NueHealth announce partnership in early cancer diagnostics

Sep 19 2016

More From Around the Web

Earnings vs. Estimates

No consensus analysis data available.